Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 275Thoracic 34Breast 25Dermatologic 17Gastrointestinal 15Genitourinary 10Sarcoma 9Head & Neck 9Endocrine 6Lymphoid 5Other hematologic neoplasm 3Gynecologic 3NET 1Myeloid 1

Conditions

Neuroendocrine Tumors 69Gastro-enteropancreatic neuroendocrine tumor 8Pheochromocytoma 7Carcinoma, Neuroendocrine 7Carcinoid Tumor 7Adenoma, Islet Cell 7Paraganglioma 6Neoplasms 5Melanoma 5Breast Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Neuroblastoma 4Neoplasm Metastasis 4Carcinoma 4Serotonin Syndrome 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neuroectodermal Tumors, Primitive 3Mesothelioma 3Meningioma 3Liver Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Anus Neoplasms 3

Interventions

entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × NET × 90 days × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡